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INTRODUCTION

The state of hyperthyroidism has been recognized as a clinical
entity for many years and with investigation into the possible causes of
this condition the theory of thyroid hypersecretion opened an era of the
first successful treatment of the condition which consisted of sub-total
extirpation of the thyroid gland.
The theory of the cause of hyperthyroidism has become markedly
more complex, the disease now being considered as a vastly more complicated hormonal imbalance than can be explained on a t~yroid basis which
has important neurologic and multiglandular associations.

Basically,

however, all successful forms of treatment have been aimed at, or have
coincidentally produced the same effect in one way or another, namely,
supression of the secretion of the thyroid gland.
The present-day management of hyperthyroidism centers about
these two forms of treatment:
l.

Sub-total ablation of the thyroid gland.

2.

Anti-thyroid drugs.

The first group mentioned above is usually preceded by treatment with
~ti- thyroid drugs.

Within the anti-thyroid drug group is a campari-

tively recent addition, thiouracil.

It is the purpose of this thesis

to draw tentative conclusions on the basis of reports in the liteFature
concerning the question:
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WH.AT, TO DATE, IS CONSIDERED THE PLACE OF

THIOURACIL IN THE TREATMENT OF HYPERTHYROIDISM, EITHER WITH OR YITTHOUT
THYROIDECTO.MY? II

1

There are different schools of thought on the status of thiouracil because eyperthyroidism is not necessarily fatal.

Occasional

spontaneous remissions occur even in the absence of any treatment.

This

is also true because methods of treatment of hyperthyroidism, which are
fairly successful, were already present before thiouracil was introduced.

Consequent],.y, the problem is to dete:rnrlne what the thiouracil-treated
patient's chances are for a complete and lasting relief, what risk,
inconvenience, and expense thiouracil-treatment subjects the patient
to, and whether thiouracil is better for one type of case or another.
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HISTORICAL REVIEW
In 1928 Chesney and co-workers (8) observed the development of
goiter in rabbits which they had kept -0n a cabbage diet.

They fo1md on

microscopic study of excised glands of these animals that they were histologically hyperplastic with decreased size of acini and with a complete
lack of colloid.

Associated with this histological picture was a decreased

heat production and a decreased basal meta1?olicaJ. rate.

Iodine was then

administered to the cabbage fed rabbits. causing a stepping-up of the metabolism and involution of the hyperplastic gland.

In 19.30, Webster and Chesney (52) noted that administration
of iodine to rabbits would prevent the goitrogenic effect of cabbage.
Other members of the Brassica group, which cabbage belongs to, were also
folllld to be goitrogenic by Marine (.38) and he further noted that the
goitrogenic powers were inversely proportional to its iodine content.
The conclusion drawn, therefore, was that cabbage contained a substance
that decreased the effective thyroxin and iodine in the tb;yroid gland,
causing hyperplasia of the gland.
The most important constituent of the Brassica group were
mustard oils which are isothiocyanates.

Consequently the effects of

isothiocyanates and their cyanide precursors were investigated.

With

acetonitrile, and chemically related compounds, !Larine (.38) produced.
hyperplasia of the thyroid gland and in some ani.mals exophthaJ.mus.
Cyanogens were also assumed to be goitrogenic since goiters were developed
in rats by feeding soy bean fiour, a substance rich in cyanogens.
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Further evidence that cyanide derivatives are goitrogenic is
manifest by the frequency of goiter in hypertensive patients given thiocyanate treatment.

Associated with marked hyperplasia and decreased

colloid of the teyroid gland is an exophthalmus, lid lag, decreased blood
iodine level and decreased basal metabolic rate, all of which return to
normal when medication is stopped ( 6) •
In 1941, Richter and Clisby (47)(48) found that when phenyl-

thiocarbamide was administered to rats they developed marked hyperplasia
of the thyroid gland and an exophthalmus.
Considering the relationship of the pituitary gland to thyroi4
secretion, Griesbach (21) studied the pituitary of rats that had been fed
soy bean ·flour and found histological. changes in the basophile cells
similar to that seen after thyroidecto.ll\Y•

The pituitary was also seen

to reflect the changes in the thyroid when rats were fed rape seed.
The basophiles increased in number when thyroid hyperplasia occurred
and the acidophilic elements accumulated when colloid storage occurred.
Fram this he concluded that the thyrotropic hormone increase in the
blood coincided with changes in the basophile cells.
Kennedy {28) and co-workers were able to show that in order
for thyroid hyperplasia to take place the hypophysis must be intact.
Vlhen hypophysectomy was performed the hyperplasia of the thyroid produced by a goitrogenic diet disappeared and colloid formation was not
prevented by the diet.
About the same ti.me MacKenzie and McCollum (36) noted that
sulfaquanadine produced thyroid }zyperplasia and hypertrophy in rats • .
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Sulfanilamide and thiourea produced simil_ar changes • .These effects were
discovered coincidentally as the above investigators were studying the
effect of these drugs on the coliform. bacteria in rats.
Kennedy (28) then attempted to show a reaction of the goitrogenic agent in rape seed and thiourea..
might be a derivative of thiourea.

He suggested that this agent

Al.lylthiourea was tested and found

to produce goiter in rats, with changes in the thyroid gland and pituitary similar to those seen after the injection of rape seed.
It was in 1943 when the MacKenzies {35) and Astwood (1) simultaneously published their results on the mechanism of the production of
goiter by sulfonamide and thiourea derivatives.

They pointed out that

these substances produced thyroid hyperplasia, a decreased metabolical
rate and tbyroidectomy changes in the anterior lobe of the pituitary.
They further showed that iodine could not counteract these changes but
that the changes could be prevented by thyroid administration or by hypophysectonw.
Astwood (2) then attempted to determine the chemic/J.]. grouping
responsible for the action of sulfonamide and thiourea derivatives.

He

also attempted to ascertain which substances were most effective with
the least ioxi.city.

He found two classes which were effective and these

included one hundred six compounds.
1.

These were:

Derivatives of thiourea thiouracil was the most effective.

2.

Derivatives of anjline dies these included the sulfonamides.
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He noted that thiocyanates were active only in the absence of iodine and
that organic cyanides were without effect.
To Astwood goes credit for first applying the newly discovered
anti-thyroid drugs to the treatment of human hyperthyroidism.
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THE EFFECT OF THIOURACIL ON THE ANATOMY OF THE THYROID GLAND
Gross Ch~.
It is now generally conceded that thiouracil produces gross
enlargement of the teyroid gland in some cases and a decrease in size
of the gland in others.

Gabrilove (16) reports that he has noticed a

primary increase in the size of the thyroid in the early stages of
treatment with later regression in size.
npticed an inmediate decrease in size.

In other patients he has
Astwood (3), on the other hand,

states that there is less frequently a d:imunition in size than is thought
because the increased softening of the gland is frequently mistaken for
decrease in size.

There were, however, instances of actual decrease in

size noted by Astwood.
some cases.

He further reports tmquestionaple enlargement in

Riker and Wescoe (49) report that there are instances in

which relatively large doses early in the course of treatment caused
increase in size of the gland with symptans of pressure and pain.

In

other cases the gland is decreased in size, especially after prolonged
treatment.
Palmer (43) in her review of cases treated with thiouracil
mentioned a group in which surgery was done because, if patients had
previous colloid goiter which had become toxic, thiouracil caused no
decrease in size after the thyroid had returned to its pre-toxic state.
Also, it was fotmd that the size of thyroid adenomata was not affected
by thiouracil.
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There is usually a softening of the gland after treatment is
begun which is assumed to result from increased vascularity produced by
the drug.
Changes in Histology:.
The general picture of a microscopic section of the thyroid
after administration of thiouracil is one of marked hyperplasia.
cells are taller than usuaJ., f-requently twenty microns high.

The

They show

a pale, granular cytoplasm with large vesicular nuclei occupying the
center of the ,c ell.
The acini have sm.aJJ. lumina and occasionally papillary infoldings though they may have obliterated lumina.
most acini is scarce.

The colloid content of

Some contain thin, stringy col.loid.

Thin walled blood sinuses traverse the gland and when compared
with normal gland, blood vessels are far more abundant in the thiouraciltreated gland.
There are occasional areas where cell outline is distorted and
where there is extensive desquamation of cells especially at points of
papillary infoldings.
In some instances the acini disappear entirely and extensive
growth of follicle epitheluim form a contiguous cellular mass.

This

might suggest a danger of neoplastic changes though incidence of neoplasm
resulting from the administration of thiouracil has not been reported.
There are occasionally small islands of lymphocytes present.
Rarely one sees an accumulation of lymphocytes into lymph follicles though
Means (41) describes an example of this after seventeen days of treatment
with thiouracil.
8

Some maintain (20) that the thiouracil-prepared gl.and appears
histologically like the gland of hyperthyroidism before the use of iodine,
and also that it is similar to that of endemic goiter.

Others (50) do

not agree with this but notice that if the thiouracil-treated and the
hyperthyroid or endemic goiter gland are compared the cells of the acini

will not be as tall and their cytoplasm not as granular in the latter.
The length of time of treatment seems to effect the histology
of the gland.

Shirer and Cohen (50), for example, report the case of ·a

sixty-seven year old white ma.le patient who received .2 gram thiouracil
three times daily over a period of seven months.

This patient had a .

diffuse toxic goiter which developed after a left lobectomy had been done
without relief of symptoms.
was 135 grams.

The total dosage of thiouracil administered

The clinical results were relief of symptoms and a drop

of the basal metabolic rate to minus three percent.

Thyroidectomy was

then done and microscopic findings revealed small and large acini, none
of them definitely hyperplastic. :Most of them were distended with colloid.
The general appearance was that of involution.

There were, however, yet

small patches of hyperplasia representing the typical picture of a thiouracil-treated gland.
On the other extreme, a case is reported (50) where thiouracil
was administered in dosage of .2 gram three times daily for only ten days
before thyroidectomy was done and the histology of the gland studied.
The patient was a thirty-one year old colored f ema.le with a diffuse toxic
goiter.

The total dosage of 6.6 grams produced a drop in basal meta-

bolic rate from plus fifty-three to plus sixteen percent.
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The gland

showed a picture of marked hyperplasia with acini which frequently had
no lumina.

The cells were tall with pale cytoplasm and vesicular, cen-

trally-located nuclei.

The picture was that of a typical thiouracil-

treated gland.
In the case (50) where iodine treatment fol.lowed treatment with
thiouracil the result was a gland that resembled that of iodine effect
alon·e.

The patient was a thirty-nine year old white female who had a

diffuse toxic thyroid.

The basal metabolic rate at the onset of treat-

ment was plus forty-nine percent.
one-half years before.

Iodine haq. been 'administered one and

Thiouracil in dosage of .2 · gram three times

daily was given but resulted in development of. a macular rash, fever
and nausea within a short time.

The drug was stopped but started again
I

in five days with retum of toxic symptoms.

Lugol s solution.

The patient was then put on

In four days the basal metabolic al. rate was down to

plus twenty-five percent and operation was perfonned.

Histologically,

the gland differed only slightly from that of the iodine-prepared gland
being somewhat more vascular and friable.

It is questionable whether

thiouracil was administered long enough to produce the thiouracil effect
on its histology.

A latent period has been described by several. investi-

gators which will be discussed later.
Just what the relations are between the histological. features
of the gland and clinical. condition of the patient is yet a matter of
much debate.

Graham (20) maintains that:- occasionally the clinical. con-

dition and histology of gland are hard to correlate.

One must take into

consideration the duration of the disease, previous iodine treatment,
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the natural history of remissions and relapses and varying degrees of
severity of the hyperthyroidism.

Even the untreated gland :mey show

various of the changes described above.

The lmowledge that the human

thyroid may undergo a cycle of hyperplasia and involution ( the Marine
cycle) must be kept in mind.

Also in man, the thyroid gland having

passed through a varying number of cycles, depending on the stage of
the disease, mey- be resistant to induced changes.

There may also be

several adenomata and foci of non-responsive teyroid tissue present.
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.M:&iHANISM OF ACTION OF THIOURACIL
It has previously been inferred that the state of hyperthyroidism is not simply one of hyper-secretion of the thyroid gland but that
there are multiglandular .associations.

Certainly the pituitary gland

must be intimately related to this dyscrinism.
Means (40) in his study of the physiology of -the thyroid gland
has gone to great effort to describe a so-called "pituitary-thyroid axis"
and has explained the equilibrium that exists between the two glands
both normall.y and in hyperthyroidism.

The diagrams below adequately

illustrate his theory.

~

~
BM-?.

(. ~ ~r

@}

T(

~

~"'

0

~

'

~
'1,

.l,

f-

~

~

Io,,

:Cl

1-,

y\

~/

,S..·

'<
1HY·

Normal Relations

Graves' Disease

0

o

'-

I

~
Exophthalmus with Minor
or no Hyperthyroidism

Although teyroxin is increased in Graves• Diseas~, it exerts its main
effect on the tissue cells and less effect on the anterior pituitary and
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TSH - thyrotropic hormone; THY - thyroid gland; TH - thyroxin).
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.

Hertz and Roberts (23) concluded after giving thyrotropic
hormone to rabbits that it causes initial stimulation of the thyroid
cells to collect iodine and if iodine is not sufficient there is exhaustion of the thyroid with resulting loss of its capacity to collect iodine.
Contrary to this finding Astwood and Bissell (5) report that the only
noticeable effect which appeared when rats were fed the thyrotropic hormone was hyperplasia of the thyroid gland.
almost normal amo\lllt of iodine.

The gland contained an

Extirpation of the pituitary was folllld

to hinder the ability of the thyroid to re-accumulate iodine after its
store had been depleted.

They also showed that thyroxin injection caused

an appearance of t~e histology of the thyroid similar to that seen in
hypop.hysectom;y.

It was concluded that under certain conditions the

administration of thyrotropic hormone promotes iodine uptake and storage
by the thyroid gland.

Absence of the thyrotropic hormone, however., hin-

ders the ability of the gland to re-accumulate iodine after its depletion.
After administration of thiouracil to rats it was observed (45)
that the thyroid took up about ten percent of radio-active iodine on the
average as compared with an average of fifty-six percent uptake in the
normal gland.

However, if the a.nirnals were treated with both thiouracil

and tl:zy'rox:in, the gland would lose about fifty percent of their iodine
content but still more than those treated with thiouracil alone.
It was on the basis of the above mentioned observations that
the theory (43) that thiouracil exerts its action by causing a block to
the uptake of iodine was devised.
is made -refractory to iodine.

The theory suggests that the thyroid

It further assumes that thiouracil does
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not act locally on the thyroid gland.

If this were true one would expect

the thiouracil-treated gland to appear histologically like one of simple
iodine deficiency which is not the case.

Furthermore, if thiouracil

causes a local block to synthesis and delivery of the thyroid hormone,
the line of reason continues, clinical feeling of improvement in patients
would follow a decrease in the circulating thyrox:i.n.

Though the level of

the circulating thyrox:i.n when this feeling of :improvement occurs has not
been ascertained, the basal metabolic rate is yet up when this begins.
Instead of a local block then, following this reasoning, thiouracil acts
as a tissue cell depressant which exerts its effects first on the most
delicate structures, that is, tissues in which there is a constantly
shifting dynamic equilibrium as in the pituitary and the adrenals.
In considering the thyroid effect of thiouracil the MacKenzies (35) in 1943 proposed the fol.lowing mechanisms as possibilities:
l.

Retention of thyroxin by the thyroid gland;

2.

Elevation of tissue requirements for thyroxin, (eg)
through the inhibition of some enzyme system;

3. Destruction or inactivation of the circulating hormone;
4.

Depression of the rate of teyraxin formation.

They suggested that results of animal. experimentations favored the
latter possibility.

Astwood (2) was conv:inced that there must be such

an interference with the production of teyroid hormone.

This was based

on the fact that presence of pituitary was found to be essential for the
production of thyroid eyperplasia with thiouracil and the other goitrogenic drug administration.

In hypophysectomized animals, administration
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of anti-thyroid drugs produced no change in histology.

Furthermore, con-

current feeding of whole pituitary powder and anti-thyroid drug in the
hypophysectomized rats _caused a maintenance of a normal histologic picture

with little evidence of teyroid stinrul.ation.
Subsequently, it was (19) hoped to show that there was
increased blood and pituitary content of thyrotropic hormone in antithyroid drug administration but it was found to be actually somewhat
decreased.

It was maintained, however, that this does not necessarily

contradict the concept of an increased thyrotropic activity in drugtreated rats but may rather indicate an increased utilization and a
resttltant :inactivation of thyrotropic hormone by an enlarging thyroid
gland.
Proof (26) that stimulation of the thiouracilized thyroid is
caused by thyrotropic hormone is shovm by the fact that the thyroid of
animals treated with thiouracil showed an :increased oxygen utilization
~

m!:2•

This increased oxygen utilization could be increased further

by previous treatment of the animals with both thiouracil and thyrotropic
hormone.
This is consistent with anatomical findings of more severe
hyperplasia of the thyroid in animals given both thiouracil and teyrotropic hormone rather than one alone

(48).

On the basis of the foregoing (48) it is concluded that in
anti-thyroid drug adm:ini.stration there is an increased thyrotropic honnone
activity not due to direct action of the pituitary but it may be looked
upon as a

11

reflex effect 11 •
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That the hypothyroid state resulting from the administration
of anti-thyroid agents is not produced by inhibition of the action of
the thyroid hormone is suggested by the f act that the goitrogenic property of any of the anti-thyroid d~s could be abolished by exogenous
thyroxin (1)(2).

The metamorphosis of tadpoles (25) produced by injec-

tion of the thyrotropic honnone could be inhibited by thiouracil while
t hat produced by thyroxin could not.
This would suggest that the synthesis of the thyroid hormone
is actually inhibited.. Malkiel (37) attempted to prove this beyond a
doubt by taking a number of mice and dividing them into f our groups into
which he injected.: . Group I - thiouracil and thyroxi.n; Group II - thiouracil; Group III - thyroxin.

Then he injected twice the M.L.D. of

acetonitrile in those that had received thiouracil alone.

in Group IL There was no mortalit y

All mice died

in the remaining groups.

The interference of the, synthesis of thyroxin in the thyroid
gland subsequently activates the pituitary which elaborates an increased
amount of thyrotropic hormone.

This results in ineffectual hyperplasia

of the t hyroid.

In an attempt to explain the mechanism by which synthesis of
thyroxin is prevented by administration of goitr ogenic drugs, Franklin
and Chaikoff (12) first demonstrated that sulfanilamide inhibited the
conversion of iodine to di-iodo-tyrosine and thyro.xin.

Bauman and .lletzger

(7) showed a rapid loss of both thyroxin and non-thyroxin iodine from
the thyroid in animals treated with tbiourea.

Even i f iodine and di-iodo-

tyrosine were administered, they had no effect and excess iodine was
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promptly excreted in the urine.

Glands made hyperplastic by administra-

tion of the thyrotropic hormone showed no loss of iodine while those
treated with thiouracil. did (5).
Confirmation of these findings was accomplished by injection
of radio-active iodine into rats as has been mentioned previously (45).
It was shoY!n that rats fed the goitrogenic drugs showed a decreased concentration of radio-active iodine of any form in the thyroid (29) and
that thiouracilized rats showed decreased incorporation of the injected
radio-active iodine into di-iodo-tyrosine and thyroxin (13).

When thi-

ouracil was withdrawn the amount of radio-active iodine converted to
thyrox:i.n increased with time.
That the hyperplasia of thyroid tis·sue produced by administration of the thiouracil and by the thyrotropic hormone was quite similar
was also noted by radio-active iodine studie~.

The gland, after with-

drawal of thiouracil showed ability to concentrate iodine in amounts
comparable to that ' of thyrotropic hormone-stimulated hyperplasia (.30).
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ABSORPTION, DISTRIBUTION AND ETJUJNA.TION

Thiouracil is rapidly absorbed from the gastro-intestional
tract.

In rats, more than eighty percent of a single dose disappeared

from the gastro-intestinal tract within two hours after administration.
In man the drug was present in the blood fifteen to thirty minutes after
oral doses of .1 to 2 grams were given (56)(57).

It is assumed th~at

essentially all of the drug not appearing in the urine was broken down
in the body or in the gastro-intestinal tract.

The amount destroyed

varies with the size and frequency of dosage, the amount of intake of
fluids, the rate of absorption from the gastro-intestional tract, the
kidney function and perhaps unlmovm factors.

The amount destroyed in

the gastro-intestional tract, when it is injected, is roughly equal to
the amounts excreted in the urine within thirty minutes after its
injection intravenously.

Destruction is apparently very rapid when the

concentration of thiouracil in the body is high but much less rapid when
the content is low.
After a single dose, peak concentrations of the blood are
reached within fifteen to thirty minutes.

Following about thirty min-

utes there is a gradual decline in the blood level until a complete disappearance occurs within forty-eight to seventy-two hours (56).

A

single dose ordinarily is .1 gram although frequently it is .2 gram.
When .1 gram of the drug is given twice daily its concentration in the
blood tends to be maintained at a higher level than when the same
quantity is given in one dose and likewise the concentration is greater
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when .1 gram is given four times daily than when .2 gram is given twice.
Generally, the individual. receiving small doses frequently maintains a
higher concentration than those given large doses less frequently.
The concentration of the drug is seven to ten times greater

in the blood cells than in plasma.

The red cells collectively contain

the greater amount of the drug though per cell., the leukocytes contain
more than the red cells.

Lymphocytes and granulocytes actively absorb

the drug from the plasma solution.
Concentrations of thiouracil were found in aJ.l body fluids,
including cerebrospinal., edema fluid, pericardial., chest, ascitic fluid,
urine and milk.

In breast milk the concentration was found to be three

times that of whole blood which will later be considered when discussing
thiouracil in pregnancy (56).
In the various tissue of the body thiouracil was found in
large quantities in bone marrow, in the thyroid, in the ovaries and in
the pituitary.
marrow.

The greatest concentration of the drug was in the bone

Smaller amounts were found in the tissue of the adrenals, pan-

creas, kidneys, spleen, liver, testis, striated muscles, brain, heart,
lung and prostate (56).
The fetuses of rats given .1 percent thiouracil in drinking
water during pregnancy were found to contain significant quantities of
thiouracil, usually about one-half the concentration of that in the
mother.

The placentae contained slightly greater concentration of thi-

ouracil than the serwn concentration of the mother.
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The small size of the

fetuses as well as the goiters attested to the physiological activity of
the drug in utero.
The amount of thiouracil present in adenomatous portions of
thyroid tissue was much greater than that in normal. sections of the same
gland.
Thyrotropic hormone administration was shown to decrease the
amount of thiouracil stored in the thyroid but potassuim iodide given
with thiouracil increased the drug storage.
Thiouracil is excreted chiefly in the urine.
found in stools.

None has been

It appears in the urine of fasting man in small amounts

thirty minutes after injection • . The normal amounts of urinary excretion
occurs during the second hour and excretion declines to very small
amounts in twelve to twenty-four hours.

The amount excreted varies with

daily dose though the precentage of total dose excreted is lower with
large doses (56).
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SIDE ACTIONS OF THIOURACIL
Hughes {25) reports that in over 700 microscopic sections
made from essentially all the body tissues, there were no notable alterations except in the thyroid gland.

Others fail to agree with him and

have noted several side effects of the drug.
Griesbach (21) in experiments with the goitrogens previous to
the discovery of thiouracil noted an increase in basophiles in the pituitarity of rats when thyroid occurred as a result of feeding rape seed.
The acidophilic elements, on the contrary accumulated when colloid storage
took place.

The YacKensies (34) likewise reported the same change of

structure of the pituitary following thiouracil and thiourea feeding to
rats and noted that withdrawal of the drug from these animals resulted
in a return of the basal metabolica.l rate and pituitary histology to
nonnal.
Apparently the activity of the anterior pituitary is not
limited entirely to thyrotropic honnone.

Leathem (31) reports that the

adrenal gland of rats treated with sulfonamides, thiourea and thiouracil
were smaller than those from animals that received no treatment.

This

is presumedly due to increased activity of the adrenotropic hormone.

No

dysfunction of the adrenal has been reported.
Gonadotrope was sim.ilarly found to be increased in amount in
the glands of thiouracil-treated rats (49).
The heart (32) of experimental animals showed atrophy of the
myocardium following administration of thiourea.
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This is likewise seen

fol;lowing thyroidectonzy-.

Slowing of the heart with an increased toler-

ance to epinephrine by the myocardium has also been observed as a result
of thiouracil administration {44) • Thyroxi.n, on the other hand, caused
decreased tolerance to epinephrine.
Riker and Wescoe (49) report hematuria and crystalline deposits
of the drug in the kidney, ureters, and bladder after large doses of
thiouracil in rats.

Palmer (17) reports three cases of crystalluria pro-

duced by the drug but after subseqUent ' Simultaneous administration of
sodium bicarbonate ha's noticed none.
,

Atrophic! changes within the glomeruli and tubules of the kidney
·have. been reported by Lebland and Hoff ( 32).

22

DOSAGE
Thiouracil has been administered in various dosages, ranging
from 2 to 0.1 grams daily.

It was soon decided that large doses are no

more effective than small ones beyond a certain limit and the trend has
been toward lower dosage • • 6 grams seems to be about the optimum maximal dose though good results have been obtained with less.

Astwood (4),

on first using the drug, gave it in doses of .2 to 1 gram daily and
found these amounts to be adequate in all cases.

Gabrilove (16) gave

0.4 to 1.0 gram daily in divided doses for the first four weeks in the
hospital.

After discharge the patients received .1 to .2 grams daily.
At present two methods (49)(46) of effective dosage are most

genera.lly used:
1. a.
b.

0.6 gram per day initiaLly.
Reduce to 0.1 to 0.2 gram daily after the basal
metabolica.l rate is nonnal.

2. a.

Initial dosage of 0.6 gram per day in three
doses of 0.2 gram each.

b.

Reduce to 0.4 gram daily when the basal rate
has dropped one-half the distance to normal.

•
c.

0.1_to 0.3 gram daily when the basal rate is
sta~ilized between plus five percent and minus
ten percent.

To counteract the depressant effect on bone marrow, cevitamic
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acid in dosage of one hw1dred mi]Jigrams per day and liver extract have
been given concomittantly (43).
Multivitamim capsules have similarly been given with the rationale that the blood levels of thiamin and diphosphothiamin were below
normal in teyrotoxic patients and tha.t pynuvic acid level was elevated

( 54). Previously it had been noted that administration of vitamin B
complex resulted in greater reduction of pulse rate, more rapid weight
gain and a shorter pre-operative period (14).
As previously stated, sodium bicarbonate has been given with
thiouracil in an effort to prevent the infrequent cases of crystalluria
that occur when the drug is administered.
10 grams with each dose

This was given in dosage of

(43). There is some debate regarding the effec-

tiveness in abolishing this complication in this manner (49).
•
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THERAPEUTIC APPLICATION
Since the evaluation of the therapeutic effects of thiouracil
depends on the response in symptoms and signs of hyperthyroidism., the
recognition of these fac~ors is important.
The classic symptoms which the patient with hyperthyroidism
presents are goiter, tachycardia, exophthalmus and tremor.

This quadrad

is incomplete and inconstant and there are a vast number of other important symptoms and signs.

It is not proposed to give a discussion of the

diagnostic significance of these various canplaints but rather it is to
be pointed out that many characteristic symptoms may be absent in some
patients with thyroto.xicocis although others may be present.

Also, the

incidence of symptoms is not always proportional to their diagnostic
significance.
Williams (53) in his study of two hundred forty-seven cases
determined the percentage incidence of the various symptoms that appear
in eyperthyroidism.

Nervousness was the most common complaint and

occurred in ninety-nine percent of the cases.

Hyperhidrosis occurred

in ninety-one percent; hypersensitivity to heat in eighty-nine percent;

palpitation in ninety-eight percent; fatigue in eighty-eight percent;
weight loss in eighty-five percent; tachycardia in eighty-two percent;
dyspnea in seventy-five percent; weakness in seventy percent; hyperorexia in sixty-five percent; eye complaints in f ifty-four percent; swelling of legs in thirty-five percent; diarrhea in twenty-three percent;

nine percent had anorexia; thirteen percent showed no loss in weight and
t wo percent showed actua.l gain.
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Likewise, on determining the incidence of physical signs in
these hyperthyroid patients he discovered that all patients were found
to have a degree of enlargement of the thyroid gland.

The degree of

enlargement varied from one-fifth to twenty-five times normal size.
Tachycardia was likewise found in one hundred percent of the patients.
The pulse rate was faster than eighty beats per minute in all cases.
Skin changes characteristic of the disease were seen in ninety-seven
percent of the patients; tremor in nin~ty-seven percent; bruit over
thyroid in seventy-seven percent; eye signs of Graves' Disease in seventy-one percent; thyroid heart disease in fifteen percent; ~uricular
fibrillation in ten percent; splenomegaly, gynecomastia and liver palms
each in about ten percent of the subjects.
The ages of all cases reported treated with thiouracil ranged
between the first and eighth decades.
the fourth decade.

The majority of the cases was in

Females were by far more conmonly effected with

hyperthyroidism., the sex ratio being estimated usually about four to
one or five to one.
The basal metabolical rate ,,.,as elevated to a variable degree
previous to treatment.

The lowest rates preceding therapy reported were

about plus fifteen percent and diagnosis on these cases Y1as chiefly on
the basis of physical signs and symptoms.

Average basal rate in cases

reported ranged from about plus twenty-five percent to plus filly percent.
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SYST:Bll OF TREATMENT
In most patients treated with thiouracil hospitalization is
apparently not necessary.

However, this has seemed to depend largely

upon the clinician who administers the drug and whether or not the drug
is yet in an experimental stage with him.
Gabrilove (16) hospitalized his patients treated with thiouracil for a period of four to six weeks .

Meanwhile he determined

basal metabolical rate before treatment and at various stages during
treatment.

He further made renal and hepatic function tests before and

after thiouracil; complete blood count two times weekly continued as
long as patient received the drug; sternal marro,i punctures at intervals
during drug administration; detennjnation of blood cholesterol levels
before and after; determination of circulation time; electrocardiograph
studies and measurements of neck size and degree exoptha.lmus once weekly.
Palmer (43) .maintained hospitalization until the basal rate
had undergone a sustained fall and then allowed the patient to return
home if he were willing to come back for weekly check-ups.
insisted upon that the patient be on a

11

It was also

small" .maintenance dose and that

there was no trend toward toxic reactions before release.

During hos-

pitalization, uninalysis and white cell count were performed every other
day and weekly blood chemistry tests were done.
Yany of Williams (47) series of two hundred forty-seven patients
were ambulatory throughout the time of treatment with thiouracil.
that were hospitalized were m the hospital no more than two days.
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Those

Patients were re-examined at first every two iVeeks for eight weeks, then
at monthly intervals for four months, and then every six to eight weeks.
Pre-operative treatment with thiouracil by the Lalley Clinic (5)
did not require hospitalization of the patients.

The patients came in

every two to three weeks for differential blood count, except those with
complications, as cardiac conditions, who returned oftener.
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CLINICAL RESULTS
Most investigations report that all cases of byperteyroidism
responded to thiouracil.

The estimates of incidence of failure of

response to the drug vary frcm two percent (46) to less than five percent

(49).

Many of these reported failures of response are thought to be due

to too short periods of administration

(16)(4).

Rate of Qlin:lCL~~esponse.
Subjective improvement in symptoms usually occurred first in
the thiouracil-treated patients

(16). This was described as a Ufeeling

of well being 11 or rtimproved physical conditionu (43).

However, there was

a marked individual variation between the beginning of treatment and
clinical response.

This was readily noticeable by some patients in a

"few days" (53); ~Y others by the end of the first or early in the second
week (16); and by a few up to six months before there was any decrease
in the basal rate.

This is used as an argwnent by some that thiouracil

acts generally as a cell depressant.

Of the subjective symptoms to

disappear first were irritability, apprehension and tension.

Following

this there was relief from palpitation thermophobia and perspiration
which came at about the time the basal rate began to drop.

The last of

the subjective symptoms to disappear was muscular ~eakness (3).
Improvement in objective symptoms usually did not occur until
there was a fall in the basal rate and usually accompanied this fall.
Astwood (3) states that decrease in the pulse rate is a good index. of
the onset of objective improvement.
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Following this decrease in pulse

rate and initial fall of basal rate there is an increase in body.weight
which continues for months.

Williams (53) reports that weight gain

usually does not occur until about two weeks after the beginning of treatment.

Following gain of weight there is a disappearance of tremor, sweat-

ing vasodilation and overactivity
J

(3).

Rate of Uetabolic_aJ,. R.e!!E!,onse.
Often the basal metabolical rate drops immediately after thiouracil is started though there are many exceptions in which there is no
apparent change in basal rate for two to three weeks (43).

At any rate,

the metabolical response is usually most marked in the first two weeks
following which initial drop there is a plateau either due to decreased
dosage or unknovm factors (3).

Generally, the higher the initial basal

rate the more sharp was the fall after the administration of thiouracil

(49)(43).
The length required for the basal rate to reach normal also
varied considerably with the individual case.
the average ti.me requirement is six weeks.

Reveno (46) states that

Riker and Wescoe (49) report

that in eighty percent of the one thousand cases studied normal basal
rates were attained within ten to forty days after -o nset of treatment.
Bartels (6) asserts that about one day of treatment has been found to be
required for each percent elevation in basal rate.
Clinical and metabolical response to thiouracil are usually
delayed in three main conditions:
1.

If iodine has been previously administered.

2.

In cases of toxic adenoma of the thyroid.
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3. If the

drug is administered to a patient with

a normal thyroid.
Iodine used prior to thiouracil occasionally caused delayed therapeutic
results.

Occasionally there was actually an initial increase in basal

metabolical rate in these instances which was assumed to be due to
storage of colloids by the thyroid gland while iodine is used, thus
causing a longer period of time to be required before the colloid can
be utilized and the effect of thiouracil can be noted (16)(49).

The

exacerbation of the disease following thiouracil administration is also
explained by the fact that increase in colloid and decrease in size of
the acinar cells of the teyroid caused by administration of iodine
antagonizes the thyrotropic hormone which in turn causes hyperplasia of
the acinar cells and promotes transfer of the thyroid hormone from the
thyroid gland into the blood stream.

Thiouracil, on the other hand,

decreases the synthesis of thyroxin but does not antagonize the action
of the thyrotropic hormone.

Therefore, on discontinuing iodine therapy,

the thyrotropic hormone is permitted to promote rapid transfer of thyroxin into the blood stream (53).
The response of thiouracil in toxic nodular goiter was
similar to that seen in patients pre-treated with iodine.

The slow

response in these cases is assumed to be due to patches in the gland
which are filled with colloid and probably store a good deal of thyroid
honnone.
Hypoteyroidism develops only after a prolonged latent period
when the normal individual is given thiouracil.
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Likewise, here it is

thought to be due to the fact that thiouracil acts specifically on
inhibiting thyroid hormone secretion and since the normal gl.and can
store more thyroid-laden colloid than · the · hypertrophied one, this will
be responsible for a latent period (53).
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SPECIFIC EFFECTS OF THIOURACIL
On Blo_o_<i Ch_~st!.7.

The blood cholesterol level has never been a good index of the
degree of hyperthyroidism.

Astwood (3) reported a rise in blood choles-

terol as a result of treatment with thiouracil already in the first
patients treated with the drug.

This rise in cholesterol usually is

concomitant with clinical improvement though it is reported (51) that
the level is often increased beyond myxedema level before the basal r~te
gives evidence of ieyxedema.

Occasionally there have been cases reported

where there is no change (16).
It is reported (51) that nitrogen, calcium and phosphorus
balances tended to become more positive during t he administration of
thiouracil.
On Renal Function.
Kidney damage has been produced(!;) experimentally by thiouracil.

There have also ' been reports of a few instances of cnystalluria (43) as
a result clinical use of the drug though the number is not significant.

On Liver Function.
Evidence of impairment of liver function has been sought for by
clinical jaundice, blood icteru.s index, cephalin flocculation tests,
urinary bile and urobilinogen estimations and galactose tolerance tests.
The onset of jaundice has been noted (51) in one case.
On ExoI?,hthalmus.

Some investigators have been hesitant about committing t heir

g3

opinions on what effect thiouracil has on exophthalmus.

There have been

some cases of definite increase in e.xophthalmus reported (43)(1~9) evf>.n t o
the extent

o:f

11

llk'1li.gnant exophthalnru.s 11 (53).

In the majority of cases,

however, exophthalmus appeared to decrease during the early months ~f
treatment.

There was usually a decreased stare and less marked widening

of the palpebral fissu.e in a few weeks .

This decrease v:as in most cases

apparently due to actual decrease in proptosis (3).

In other cases the

decrease in exopthalmus was merely a manifestation of increased weight
with increased subcutaneous fat and a decrease in lid retraction (3)(49).
Some adndnistered thyroid extract simultaneously and found it .to produce
some nbeneficial effect" in relieving e.xophthalmus (49)(43)(53).
HyperthY:roidism with complications.
Thyrocardiacs are assumed to be toler ant t o thiouracil and the
dnJ.g is in no way counter-indicated in this condition.

In cases of

cardiac decompensation due to latent hyperthyroidism or in m:ild toxic
states more thiouracil seemed to be r~quired to affect the pulse pressure
and to control t he t hyrotoxic symptoms (43).

Instances of auricular

fibillation and flutt~r ~ve on the contrary been treated without effect
on t he rhythm {16).

In several cases reported, concomittant adminis-

tration of quinidine caused fibrillation to revert to nonnal rhythm.
However, if the disturbance in heart rhythm is caused only by thyrotoxicosis, it is now generally asswned that thiouracil alone will cause
a retum to normal rhythm.
Thiouracil has been administered in diabetes with fairly gratifying results.

Astwood (4) had a case of hyperthyroidism complicated
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by diabetes among the first group of patients to which thiouracil was
administered.

He described clinical improvement of the hyperthyroidism

as well as a decreased glycosuria which fol.lowed the establishment of a
normal ]:>asal metabolical. rate.
others (49)(53).

His findings have been confinned by

Other instances of complete disappearance of glycosuria

in hyperthyroid diabetes have been cited

(49).

On the contrary, there

have been .reports of failure of thiouracil in hyperthyroid diabetics.
Gabrilove (16) noticed no improvement of either of the conditions nth
thiouracil treatment. :McGavack (33) al.so failed to notice response in
these patients.
:Much divergence of opinions yet exists concerning the advisability of feeding thiouracil to patients during pregnancy.

This lack

of agreement has arisen from investigation of thiouracil concentration
and dis~ribution within the body elements as well as some reports as to
result s obtained clinically and on experimental animals.
It has al.ready been mentioned that in experimental animals
the fetuses contained a drug concentration of one-hal.f that of the
mother.

The concentration ill the placenta was somewhat greater than that

in the mother.

It was further mentioned that the concentration of thi-

ouracil in breast milk is three times that of whole blood.
There are several reports of fetal :injury as a result of thiouracil treatment during pregnancy.

Hughes (25) reports that the young

of thiouracil-treated rats appeared normal at birth but had hyperplastic
thyroids and showed retardation in growth after about the tenth day.
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Eaton (9) also reports a baby bom with goiter as a result of the drug.
However, he blames it onto a greater dosage than others were getting in
this instance.
There have, however, been reports favorable to thiouracil
administration during pregnancy which outnumber the unfavorable ones.
Eaton (9) mentions one case where the drug was given all during pregnancy
until one month prior to delivery when iodine was substituted.
fetus and mother were in good condition at birth.

Both

Five months after

birth the child's thyroid, which was palpable at delivery, had receded
to normal size.

Riker and Wescoe (49) cite three instances vrhere no ill

effects followed thiouracil administration.

Three patients were treated

before and during entire pregnancy by Williams (53).

One patient was

treated during the last six weeks of pregnancy and one during the last
month.

All babies were

m excellent condition at birth and none showed

a goiter at birth.
None of the investigators reporting results of thiouracil
in pregnancy mentioned whether or not the children were breast fed.
·rhis should be important.
Astwood (3) reports treatment of two patients with hyperthyroidism superimposed on acromegaly with thiouracil.
rate fell but not to normal.

In one the basal

The patient subsequently died and examina-

tion of the thyroid after death showed that it contained a high iodine
content.

In the other, thiouracil caused no improvement of clinical

symptoms or basal rate.
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The patients with toxic nodular goiter, as has already been
mentioned, showed a longer latent period before clinical response than
those v.rith a diffuse goiter.

In some instances early

in the use of the

drug, this was interpreted as a refractoriness to the drug but response

in these patients after prolonged treatment disproved such assumptions.
Remission.
All literature concludes that there is eventual remission of
hyperteyroidism in practically all patients treated with thiou,racil as
long as the drug is continued.

Less of the drug is needed to maintain

remission as the disease subsides, probably due to the larger amounts of
thiouracil stored in the thyroid when the activity of the thyroid honnone
is normal than when it is increased.

However, we are more interested in

what the patient's chances are for a full and permanent cure after the
drug has been withdrawn.
Of all cases reported, it is estimated that about ten percent
continued satisfactorily after thiouracil had been withdrawn (53)(46).

.

The length of time the patients have gone without the drug varies considerably and in some instances it is yet hard to determine whether or
not there will eventually be a return of symptoms.

There have been

attempts to set up a group of criteria, on the basis of clinical experience, useful in predicting relapse on remission aft er the drug has been
withdrawn.

These we shall mention.
There is a definite relationship between the duration of treat-

ment and tendency to maintain remission after discontinuance.

Astwood

(3) advises at least six months treatment before attempt of withdrawal
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is made.

Williams ( 53) asserts that the longer t he patient is treated,

the longer the interval of non-treatment preceding relapse.
however, exceptions to this.

He favors treatment

There are,

of nine months

longer if permanent cure with the drug alone · is t he objective.
one decide when it is time for discontinuance of drug?
no definite criterion for this.

or
How can

There is as yet

Astwood (3) suggests that it is pos-

sible that the size and vascularity of the gland are important factors.
The bruit must be absent.
The age of the patient or duration of the disease (53) are
in no way related to incidence of relapse and cannot be used as a

criterion for prognosis.
significance.

The. sex of patient~ have some prognostic

It is reported that males experienced relapse more fre-

quently than females.

Nodttl.o:r goiter s responded as well as diffuse in

Williams• (53) series of patients.

Palmer (43), however, observed no

nodular thyroid to have remission longer than four months.
Patients (53)(3) with only slight enlargement of t he thyroi d
gland demonstrated a higher incidence of re.mission than those with
larger goiters.

However, some very large glands sustained remission.

Patients who have remission show a 11 distinctly greater tendency" for a
decrease in size of the gland than patients who experienced relapses.
Patients with a moderately increased basal rate showed
remission more often than those with markedly increased rate.
The ex:ophthalmus also appeared to be more malignant in those
patients who did not show r emission.
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There appears to be no relation of the dosage of thiouracil
or t he rate of drop of basal rate and remission.

X-ray and thyroxin

administration also did not appear to influence the rate of remission.
Thiouracil Used Pre-operative].y.
There is at present little disagreement concerning the statement that thiouracil has a place in pre-operative preparation of the
hyperthyroid patient but also that if used alone it produces certain
undersirable S':,ll'gical complications.
The reasons for thyroidectomy varied.

Some (6) considered

thiouracil not as a substi~ute for thyroidectomy in any case but did
thyroidectomies routinely on all hyperthyroid ~ t ients of significant
severity.

Others (43) resorted to surgery because of conditions, where

previous large colloid goiters, which .had become toxic, were not decreased in size after the thyroid gland had returned to its pretoxic
state under thiouracil administration; also where large adenomata which
were not effected by thiouracil were present.
gery was chiefly for cosmetic purposes.

In these instances sur-

Occasionally it was necessary

to do surgery because of refractoriness to thiouracil and in some
instances because of toxic reactions in the drug.

Finally surgery was

done because certain patients found it difficult or impossible to
return regularly for check-ups under thiouracil management.
The Lahey Clinic (6) found that the maximum amount of improvement must be obtained by thiouracil before operation is attempted.
The basal rate 1ID1st be as nearly normal as possible and the symptoms
must be absent.

Others (43) suggest that the basaJ. rate must be down
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one-third or one-half but not necessarily as low as plus ten percent
because the physiologic equwbruim is reached some time before it is
reflected in the basal rate.
maximum

Bartels (6) reports two 'patients where

improvement was not obtained pre-operatively.

The operative

course was so unsatisfactory that only hemi-thyroidectonzy- was possible
and the post-operative course was stonny.
Thiouracil delivers the patient to surgery more dependably in
a euthyroid state than was ever possible with iodine.

Thyroxtic reactions

(53) are less during and immediately following operation than in comparable patients treated with iodine.

It is now thought

.

(53)(6) that hemi-

t.hyroidectomies, which iodine pre-operative medication made necessary in
many patients, are now unnecessary because of smooth anesthesia and the

smooth post-operative course that

11

always" follows thiouracil-treated

tbyroidectomies.
There are, however, as mentioned, undesirable surgical complications in all patients receiving thiouracil alone.
to be soft and f~able and bleeding is extensive.

The gland is found
To overcome this the

Lahey Clinic advocates thiouracil until the basal rate is at least down to
plus twenty, by beginning· iodine three weeks pre-operatively and discontinuing thiouracil one week ·p re-operatively.
involution in most cases.

This produces satisfactory

Williams (53) -suggests use of iodine both

before and during thiouracil treatment for best results.
There are reports

(16)(43) of excellent results with thiouracil

used preoperatively without added iodine administration.

This was pro-

bably due to the fact that these were cases of primary hyperthyroidism
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of long standing where spontaneous involution over the years is sufficient to prevent the gland from bleeding excessively or adenomatous
goiters where the gland remained firm in spite of thiouracil treatment.
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TOllCOLOGY
The fact that long periods of treatment with thiouracil are
necessary to produce remission of hyperthyroidism and that i n ~
instances permanent remission after withdrawal can obviously not be
obtained with the drug would alone not make us hesitate to use the drug
exclusively for treatment of hyperthyroidism.

However, there is a 11 fly

in the ointment" and this consists _o f the toxicity of thiouracil.

The toxic reactions resulting from thiouracil administration
have been estimated to occur in not ov~r 14.5 percent of patients
treated and fatalities due ~o the drug in not over .5 per cent (39).
This compares favorably with incidence of tetanies and vocal cord paralysis occurring in about one percent of thyroidectomi.es and likewise
a fatality rate of .5 percent in surgery (39).

However, one must not

fail to consider that the risk extends over a much longer period of time
in the administration of the drug than with surgery.

If the peace of

mind of the physician and of the patient is a factor, this is si.:,onificant.
Tze,es of Reactions.
Throughout the literature that was reviewed, the following
enumeration includes most of the toxic reactions that have been reported:
agranulocytosis, arthritis,_ diarrhea, enlargement of salivary glands,
edema of the legs, fever, generalized enlargement of lymph nodes, headache, hematuria, icterus, leukopenia, nausea and vomiting, rash and
urticaria and pu.rpura.
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T·he terms agranulocytosis and leukopenia must first be
differentiated and defined.

Williams (53) has arbitrarily described

agranulocytosis as applying only to patients experiencing a decrease
in the total white blood cell count to about two thousand or below, and/

or a decrease in the granulocytes to about two percent or lower.

The

presence of infection is not regarded as a requirement for this designation.

To have a small percentage of granulocytes seems to offer a

far better prognosis than to have none.
The term leucopenia is generally applied by hematologists when
the leucocyte count is less than five thousand.

However, in dealing

with thyrotoxic patients one must bear in mind that leucopenia and neutropenia may occur in tµitreated cases.

It is therefore often difficult

to differentiate between the leucopenia of th,yroxicosis and that due to
thiouracil.

Williams (53) here also has designat ed an arbitrary figure,

namely, leucocyte counts below three thousand five hundred as being
due to the toxic action of the drug, and most of those below four
thousand as probably being due to the drug.
The incidence of agranulocytosis has been estimated as occuring in not over 2.5 percent of all cases treated with thiouracil (39)

though individual reports usua.l.ly describe a lower incidence.

Williams

(53) reports an incidence of .6 percent in series of seven hundred
ninety-three reported cases.

Leukopenia occurred in about 4.8 percent

of these cases.
Although generalized aching and malaise were associated with
several of the toxic reactions, significant joint changes occurred in
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less than .1 percent of the cases.

Williams (53) describes one case in

which an acute inflanmation of many joints occurred, along with fever
and urticaria appearing after two lveeks of thiouracil treatment but on
cessation of the drug therapy, the reactions rapidly disappeared.
Diarrhea has been reported by some clinicians, as a toxic manifestation of thiouracil.
ible (4).

Usua.J.:cy it is severe and occasionally intract-

It occurred shortly after therapy was introduced and believed

by some to be a manifestation of too large dosage and not a toxic
reaction

(53).
Enlargement of the submaxillary salivary glands has been

reported in one case (54).

Experimentally it was found that thiouracil

decreases the peroxidase content of subma:xillary glands (53).

Whether

this has anything to do with enlargement is not lmown.
Edema of the legs developed in some patients without any
evidence of renal or cardiac damage.
described (16).

Generalized edema has also been

The total serum protein concentration was normal, but

in some instances there was evidence of retention of sodium chloride in
the body.

It seemed to occur in patients receiving larger doses of the

drug (daily doses of one

gra.m)(53).

Fever has been given as an indication of impending danger of
toxic reactions by some (4).

It has been estimated to occur in about

three percent of the patients treated with thiouracil (53).
Generalized enlargement of lynq::a nodes has been observed and
reported (15)(42)(16) in a few instances.
not a manifestation of drug toxicity.
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Some suspect that this was

Headache developed in occasional patients but quite infrequently
when the dosage remained small.

Dai:cy dosage of one gram seemed to cause

headache in a significant number of patients to make one suspect that
dosage was the factor responsible (53).

In a very few cases hematuria has been attributed to thiouracil

(43). Very large dosage of thiouracil

in rats produced no kidney changes

(58).

Icterus has been reported
enchyma.tous liver changes

(17)(27)(51)

in a few cases and par-

(51) have also been seen.

Nausea and vomiting seemed to occur mainly in those cases where
large dosage were administered and shortly after beginning treatment.
Incidence of such reaction has not been significant where dosage was
small (53).
Most investigators who have treated many patients have observed
development of a maculo-papular rash.
distribution.

It usually showed a generalized

Urticaria was usually associated with the rash and occas-

ionally there was also fever in these cases

(16).

A thrombocytoperic purpura has been described as it occurred

in one patient (10).

Others have noted a few cases of spontaneous

ecchymoses without a thrombocytopenia and without apparent vitamin C
deficiency (53).
Factors Related to Toxic Reactions.
Among all reports concerning toxic reactions, it appears that
the age of the patient, the sex of the patient, the type and rate of
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response of the hyperth;y'roidism, the concentration of thiouracil in the
blood and the total dosage of the drug seemed to be unrelated to toxic
reactions.
The general condition of the patient did seem to be related
to toxic reactions according to some reports.

Two patients who died of

agraulocytosis seemed to be in very poor general condition (11)(27); one
patient (27) had diabetes, weigheq only seventy-seven pounds and was
sixty-two years old.

Others report that the condition of the patient did

not seem to play a significant part (53).
Manifestations of sensitivity of patients to other substances
has been reported.

Some patients developed a rash when put on iodine

after thiouracil was withdrawn (53).

_

Some patients who developed

leucopenia to thiouracil had previously developed skin rashes to phenobarbital.

Astwood (3)(4) reports a patient who developed and recovered

from agranulocytosis due to thiouracil and later developed a febrile
reaction to sulfathiazole and a scarlatiniform eruption to phenobarbital.
Conversely, there were other patients who had shown previous sensivivity
to iodine 1 sulfadiazine and phenobarbital but did not react to thiouracil.
As has been mentioned, the total dosage of thiouracil apparently is not
significant in determining reactions.
seems to be important.

The total daily dose, however,

Slightly over one-half the cases of leukopenia

noticed by Williams (53) had what is not considered too large daily
doses.

Seven-eighth of the cases of agranulocytosis were likewise s~en

in patients getting one gram daily.
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Other reactions already mentioned

seemed to depend directly on dosage.

On the contrary, fever and urticaria

did not seem to be lated to dosage.

The duration of treatment with thiouracil prior to onset of
reactions varied considerably for different reactions and for the same
reactions.

Agranul.ocytosis occurred most frequently five to eight weeks

after the onset of therapy.

There were, however, instances where it

occurred after four to el.even months of treatment and in one instance
after the third course of therapy was begun (53).
Leucopenias appeared most often during the first four months
of treatment.

A slight decrease in white blood cells has been described

to occur when treatment is started and a mean drop of seven hundred
during the first month of treatment has been observed (9).

Leucopenia

has also been reported as suddenly developing after twelve to fourteen
months of treatment.
The question arises whether thiouracil should be continued in
spite of appearance of leucopenia.

Continuation of thiouracil therapy

may change some benign leucopenias into agranul.ocytosis though sane
leucopenias disappear in spite of continued therapy.

Just how long it

takes for the leukocyte count to change from a normal level to agranulocytosis is not known.

Sometimes the white cell level returns to nonnal

even thiouracil is continued but later a decrease is noted (53).

In most

of these where thiouracil was withdrawn and resumed after the reaction
disappeared leucopenia developed within forty-eight hours to five weeks
after thiouracil was started for the second ti.me (53).
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However, there

are also reports (43) of cases in which reswnption of treatment, after
reactions disappeared, produced no recurrence of reactions.

Many of the febrile reactions reported developed between the
seventh and eleventh day (3)(6)(15) .

In other instances fever did not

develop until up to eighteen months after onset of treatment.

In

practically all cases reswnption of treatment after fever was down produced recurrences.
The rash appeared in the first few weeks but tended to disappear in spite of continuance of thiouracil within a few days.

Edema

appeared in the first month, Urticaria, headache, nausea, vomiting and
diarrhea in the first few weeks.
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CONCLUSIONS
Tl;rl.-0uracil is of great aid in the treatment of eyperthyroidism,
whether used in conjunction with thyroidectamy or not.

It is not neces-

sary to use thiouracil in all cases of toxic goiter because in certain
patients iodide is just as effective as thiouracil in controlling the
disease, and in patients treated with iodide the technical difficulties
of tbyroidectollij" do not tend to be as great as in ones treated with thiouracil.

Moreover, the incidence of toxic reactions is less with iodide

than with thiouracil.

Although the effectiveness with which iodide can

control a given case of tbyrotoxicosis is often unpredictable, this is
no serious drawback to a trial with it, because if the iodide is found
to be unsuccessful thiouracil treatment can then be used in conjunction
with the iodide.

There are some patients with tbyrotoxicosis to whom it

seems imperative that thiouracil be given, as for example, individuals
with severe disease which is refractory to iodide therapy and associated
with heart failure.
severe cases.

Indeed, the drug is quite desirable in many less

However, it is welcomed for that group of patients who

seemingly would prefer to die of thyroto.xicosis than be subjected to
tbyroidecto.my.
Whether it is wise to plan to treat most instances of toxic
goiter with thiouracil and v..-ithout teyroidectOllij" is still in the realm of
investigation.

The most significant handicap to such a plan is the nature

and relative frequency of the toxic reactions to thiouracil.

This, how-

ever, has by no means settled the question; the chief point awaiting
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elucidation is a determination of the proportion of patients who will
attain sustained or permanent remissions of the thyrotoxicosis on
cessation of all antithyroid treatment.

To be sure, the latter point

would be less significant if the toxic reactions were less prominent
since the drug could be used more or less indef initely •

.
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